Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 3, 2005, Pages 1298-1304

  Cao, Ying Jun ^a   Surowy, Carol S ^a   Puttfarcken, Pamela S ^a,b  

^a ABBOTT LABORATORIES   (United States)

^b Neurol and Urological Dis Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE; 5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; [(2 CHOLORO 5 PYRIDYL) 9 AZABICYCLO NON 2 ENE]; [N,N,N TRIETHYL 2 [4 2(2 PHENYLETHENYL)PHENOXY] ETHANAMINIUM IODINE; ALKENE DERIVATIVE; ALPHA BUNGAROTOXIN; ALPHA CONOTOXIN MII; ANATOXIN A; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; EPIBATIDINE; HEXAMETHONIUM; IODINE DERIVATIVE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG RELEASE; DRUG SELECTIVITY; HIPPOCAMPUS; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AZETIDINES; BRIDGED COMPOUNDS; DOPAMINE; HIPPOCAMPUS; MALE; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; PYRIDINES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; STILBENES;

EID: 14344249795     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.076794     Document Type: Article

References (39)

1. 3H]-NE from rat brain slices using a new 96-well format assay. Neuropharmacology 38:2663-2672.
2. Azam L, Winzer-Serhan UH, Chen Y, and Leslie FM (2002) Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 444:260-274.
3. Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, and Menzaghi F (2003) Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacology 28:1235-1246.
4. Brazell MP, Mitchell SN, and Gray JA (1991) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose response and antagonist study. Neuropharmacology 30:823-833.
5. Charpantier E, Barneoud P, Moser P, Besnard F, and Sgard F (1998) Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport 9:3097-3101.
6. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4, and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
7. 3H]-dopamine release. Br J Pharmacol 117:595-606.
8. Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Rang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, and Sullivan JP (1995) Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur J Pharmacol 280:79-89.
9. Di Angelantonio S, Nistri A, Moretti M, Clementi F, and Gotti C (2000) Antagonism of nicotinic receptors of rat chromaffin cells by N,N,N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study. Br J Pharmacol 128:1771-1779.
10. Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, et al. (1998) ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. J Pharmacol Exp Ther 285:777-786.
11. el-Bizri H and Clarke PBS (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br J Pharmacol 111:406-413.
12. Gotti C, Balestra B, Moretti M, Rovati GE, Maggi L, Rossoni G, Berti F, Villa L, Pallavicini M, and Clementi F (1998) 4-Oxystilbene compounds are selective ligands for neuronal nicotinic α-bungarotoxin receptors. Br J Pharmacol 124:1197-1206.
13. Gotti C, Carbonnelle E, Moretti M, Zwart R, and Clementi F (2000) Drugs selective for nicotinic receptor subtypes: a real possibility or a dream? Behav Brain Res 113:183-192.
14. Horn AS (1990) Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 34:387-400.
15. Jay TM (2003) Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69:375-390.
16. Kiss JP, Windisch K, Balla A, Sershen H, and Lajtha A (1997) Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res Bull 43:257-262.
17. Klink R, de Kerchove d'Exaerde A, Zoli M, and Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452-1463.
18. Levin ED and Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217-230.
19. Luetje CW and Patrick J (1991) Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845.
20. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, and McIntosh JM (1998) α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18:8571-8579.
21. Maggi L, Palma E, Eusebi F, Moretti M, Balestra B, Clementi F, and Gotti C (1999) Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick α7 nicotinic receptor. Br J Pharmacol 126:285-295.
22. 3H-GBR 12935. J Neural Transm Gen Sect 87:1-14.
23. Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53-83.
24. Papke RL and Heinemann SF (1994) Partial agonist properties of cytisine on neuronal nicotinic receptors containing the β2 subunit. Mol Pharmacol 45:142-149.
25. 3H]-dopamine release from rat cortex and striatum. Neuropharmacology 39:2673-2680.
26. Puttfarcken PS, Manelli AM, Arneric SP, and Donnelly-Roberts DL (1997) Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells. J Neurochem 69:930-938.
27. Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, and Vernier JM (2003) In vitro pharmacological characterization of (+)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand. Brain Res 981:85-98.
28. 3H]-dopamine release from striatal synaptosomes: pharmacological characterization. J Neurochem 54:937-945.
29. Richelson E and Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277-286.
30. Romanelli MN and Gualtieri F (2003) Cholinergic nicotinic receptors: competitive ligands, allosteric modulators and their potential applications. Med Res Rev 23:393-426.
31. Sharples CG, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, Wright E, Spencer JA, Gallagher T, Whiteaker P, et al. (2000) UB-165: a novel nicotinic agonist with subtype selectivity implicates the α4β2 subtype in the modulation of dopamine release from rat striatal synaptosomes. J Neurosci 20:2783-2791.
32. Sharples CG, Karig G, Simpson GL, Spencer JA, Wright E, Millar NS, Wonnacott S, and Gallagher T (2002) Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (±)-UB-165. J Med Chem 45:3235-3245.
33. Smialowski A and Bijak M (1987) Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors. Neuroscience 23:95-101.
34. Stauderman KA, Mahaffy LS, Akong M, Velicelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, et al. (1998) Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J Pharmacol Exp Ther 284:777-789.
35. Tatsumi M, Groshan K, Blakely RD, and Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
36. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, and Swanson LW (1989) Distribution of α2, α3, α4 and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in rat. J Comp Neurol 284:314-335.
37. Waud DR (1968) Pharmacological receptors. Pharmacol Rev 20:49-88.
38. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
39. Yu CR and Role LW (1998) Functional contribution of the α5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurons. J Physiol 509:667-681.